Table 5. CR, OS, and EFS in 1560... | American Society of Hematology

Table 5.

CR, OS, and EFS in 1560 patients for whom clinical data are available

	Total no. patients	No. patients			CR					Median OS					Median EFS
	Total no. patients		NRAS^mut	*NRAS^WT*	NRAS^mut, %	NRAS^WT, %	P	NRAS^mut, d	NRAS^WT, d	P	NRAS^mut, d	NRAS^WT, d	P
All patients	1560	160	1400	60.6	55.7	.340	1490	604	.096	424	335	.146
Normal karyotype	733	59	674	65.9	64.2	.620	1012	737	.934	368	352	.947
All intermediate karyotypes	299	27	272	62.7	60.9	.748	310	436	.672	187	303	.138
inv(16)	113	41	72	66.7	71.8	.429	NR	NR	.456	918	769	.956
inv(3)	20	4	16	NA	NA	NA	100	752	.320	100	296	.835
t(8;21)	116	13	103	80	62.8	.250	NR	882	.453	NR	648	.175

	Total no. patients	No. patients			CR					Median OS					Median EFS
	Total no. patients		NRAS^mut	*NRAS^WT*	NRAS^mut, %	NRAS^WT, %	P	NRAS^mut, d	NRAS^WT, d	P	NRAS^mut, d	NRAS^WT, d	P
All patients	1560	160	1400	60.6	55.7	.340	1490	604	.096	424	335	.146
Normal karyotype	733	59	674	65.9	64.2	.620	1012	737	.934	368	352	.947
All intermediate karyotypes	299	27	272	62.7	60.9	.748	310	436	.672	187	303	.138
inv(16)	113	41	72	66.7	71.8	.429	NR	NR	.456	918	769	.956
inv(3)	20	4	16	NA	NA	NA	100	752	.320	100	296	.835
t(8;21)	116	13	103	80	62.8	.250	NR	882	.453	NR	648	.175

NR indicates not reached; NA, not available.